Clinical Trials on Liquid Oxycodone in Australia
Total 179 results
-
The University of Western AustraliaNational Heart Foundation, AustraliaCompletedObesity | Cardiovascular Disease | Lipid DisordersAustralia
-
HighTide Biopharma Pty LtdCompletedHypercholesterolemiaAustralia
-
Swisse Wellness Pty LtdCommonwealth Scientific & Industrial Research Organisation; BIONAP SRLCompletedInvestigating Effects of a Novel Nutraceutical on Hypercholesterolaemia in Australian Adults (CLoNE)HypercholesterolemiaAustralia
-
The University of Western AustraliaNational Health and Medical Research Council, AustraliaUnknownFamilial Hypercholesterolaemia | HypertriglyceridaemiaAustralia
-
AmgenCompletedPrimary Hyperlipidemia and Mixed DyslipidemiaAustralia
-
University of South AustraliaAmerican Egg BoardCompletedHypercholesterolemia | Hyperlipidemias | Diet, Healthy | Physical InactivityAustralia
-
Chong Kun Dang PharmaceuticalCompleted
-
LipimetiX Development, LLCCompletedHypercholesterolemia | Hyperlipoproteinemia Type IIAustralia
-
Marea TherapeuticsRecruiting
-
AstraZenecaCompletedMetabolic Syndrome | DyslipidemiaAustralia
-
The University of Western AustraliaCompletedObesity | Insulin Resistance | DyslipidemiaAustralia
-
The University of Western AustraliaCompletedObesity | Insulin Resistance | DyslipidemiaAustralia
-
Resverlogix CorpSouth Australian Health and Medical Research InstituteTerminatedCoronary Artery Disease | DyslipidemiaAustralia
-
The George InstitutePfizer; Royal Prince Alfred Hospital, Sydney, Australia; Lipid and Cardiovascular... and other collaboratorsCompletedHypercholesterolemiaAustralia
-
AstraZenecaCompletedMetabolic Syndrome | DyslipidemiaAustralia
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
Arrowhead PharmaceuticalsCompletedHypertriglyceridemia | Familial ChylomicronemiaAustralia, Canada, New Zealand
-
Kirby InstituteNational Heart, Lung, and Blood Institute (NHLBI); The University of New South... and other collaboratorsCompletedHIV Infections | Cardiovascular Disease | Lipodystrophy | Glucose Metabolism | Lipid Metabolism | Metabolic AbnormalityAustralia
-
Barmherzige Brüder LinzCompletedSepsis | Inflammation | Lipid Metabolism Disorder | LPSAustria
-
ISU Abxis Co., Ltd.CompletedGaucher DiseaseAustralia
-
Monash UniversityNational Health and Medical Research Council, AustraliaActive, not recruitingHeart Failure | Atrial Fibrillation | Hypercholesterolemia | Healthy AgeingAustralia
-
Ikaria Bioscience Pty LtdRecruitingTo Reduce the LDL-C Level in Hypercholesteremia Adult Patients | Combination for Subgroup High LDL-c Patients With Other ComorbiditiesAustralia
-
Bristol-Myers SquibbCompletedDyslipidemia | Diabetes Mellitus, Non-Insulin-DependentAustralia
-
Silence Therapeutics plcMedpace, Inc.CompletedDyslipidemias | Hyperlipidemias | Elevated Lp(a)United States, Australia, United Kingdom, Netherlands
-
Western Sydney Local Health DistrictCompletedMetabolic Syndrome | HypercholesterolemiaAustralia
-
Affiris AGMedical University of ViennaCompleted
-
Medical University of GrazCompletedFluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular RiskHypercholesterolemiaAustria
-
Arrowhead PharmaceuticalsActive, not recruitingHomozygous Familial HypercholesterolemiaAustralia, Canada, United States, South Africa
-
Medical University of ViennaUnknown
-
Austrian Academic Institute for Clinical NutritionMedical University of ViennaCompletedHeterozygous Familial HypercholesterolemiaAustria
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, Australia, United States
-
Vaxxinity, Inc.Novotech (Australia) Pty LimitedActive, not recruiting
-
Amicus TherapeuticsCompleted
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Australia, Austria, Netherlands, Taiwan, Ukraine
-
Unilever R&DCommonwealth Scientific and Industrial Research Organisation, AustraliaCompletedVascular Diseases | Diabetes Mellitus | HypercholesterolemiaAustralia
-
Medical University of ViennaUnknown
-
4D Molecular TherapeuticsActive, not recruiting
-
Amicus TherapeuticsCompletedFabry DiseaseAustralia, Brazil
-
Melbourne HealthSanofiWithdrawnLysosomal Storage Diseases | Fabry Disease | Niemann-Pick Disease, Type C | Gaucher DiseaseAustralia
-
University College, LondonUniversity of Sydney; University Hospital BirminghamUnknownFabry DiseaseUnited Kingdom, Australia
-
Kirby InstituteNational Heart, Lung, and Blood Institute (NHLBI); St Vincent's Hospital, Sydney and other collaboratorsCompletedGlucose Metabolism Disorders | Metabolic Diseases | HIV Infections | Cardiovascular Disease | Dyslipidemias | LipodystrophyAustralia
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, Australia, Austria, Canada, France, Greece, Italy, Japan, South Africa, Ukraine
-
German Diabetes CenterMedical University of ViennaCompleted
-
Medical University InnsbruckUnknownFamilial Hypobetalipoproteinaemia - Heterozygous Form | Low-LDL-syndromeAustria
-
Kirby InstituteBristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Gilead Sciences; Hoffmann-La... and other collaboratorsTerminatedHIV Infections | HIV-Associated LipodystrophyAustralia
-
Vorarlberg Institute for Vascular Investigation...CompletedInflammation | Insulin Resistance | Lipid MetabolismAustria
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
Amicus TherapeuticsCompletedFabry DiseaseFrance, Austria, United States, Belgium, Japan, United Kingdom, Denmark, Brazil, Australia, Italy
-
Klinikum Wels-GrieskirchenGenzyme, a Sanofi CompanyCompletedFocus of Study: Prevalence of Fabry Disease in CKD PopulationAustria
-
Glycemic Index Laboratories, IncUniversity of Toronto; University of Guelph; University of Sydney; Agriculture... and other collaboratorsCompletedHypercholesterolemiaCanada, Australia, United Kingdom